Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT06452849. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT06452849
Amygdala and dLPFC MRI-TIS for Depression in Adolescents
This study is recruiting. It focuses on depression and currently lists participation information in China.
DepressionDeviceFrom 14 Years to 18 Years
Key information made simple
This study is looking at care and outcomes for people with depression. Taking part may give some people access to Nervio-X, but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a clinic, with sites including Shanghai Pudong New Area Mental Health Center. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable and safety concerns that need urgent care first. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
- Sponsor type
- University
- Main activity
- medication or study treatment
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Amygdala and dLPFC MRI-TIS for Depression in Adolescents
- Condition
- Major Depressive Disorder
- Study status
- Recruiting
- Sponsor / lead affiliation
- Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
- Location / country
- China
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT06452849
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in China.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Amygdala and dLPFC MRI-TIS for Depression in Adolescents
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT06452849
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Amygdala and dLPFC MRI-TIS for Depression in Adolescents?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me